How Long Does Cocaine Stay in Your System?

Cocaine itself stays in your system for roughly 1 day, but the metabolite drug tests actually look for, benzoylecgonine, remains detectable in urine for up to 4 days according to Mayo Clinic Laboratories.

That gap is the single most useful thing to understand here. Your body clears cocaine quickly and then carries the evidence far longer.

Dose, frequency, and whether alcohol was involved all shift the result. Drinking alongside cocaine changes what a urine test finds, not just how long it finds it.

Which test is being run, and what threshold it applies, explains nearly every disagreement between published figures.

Key Takeaways

• Mayo Clinic Laboratories reports that cocaine is present in urine for about 1 day after last use, while its major metabolite benzoylecgonine is detectable for up to 4 days.
• Standard tests do not look for cocaine. Urine immunoassays target benzoylecgonine, which is why the metabolite half-life of roughly 12 hours matters more than cocaine’s own.
• Research using a 5 ng/mL assay rather than the standard 100 ng/mL cutoff extended the detection window to between 17 and 22 days.
• Co-ingestion produces cocaethylene and reduces cocaine’s hepatic clearance, increasing unchanged cocaine in urine while lowering total metabolite output.
• SAMHSA’s 2024 survey puts past-year cocaine use at 1.5 percent of people aged 12 or older, down from 1.7 percent in 2021, while adolescent use rose.

What Does the Body Turn Cocaine Into?

Cocaine converts within hours into benzoylecgonine and ecgonine methyl ester, and it is those metabolites, not cocaine itself, that drug tests detect.

The Two Metabolites That Matter for Testing

• Benzoylecgonine is the predominant metabolite: Mayo Clinic Laboratories identifies it as the main product of cocaine metabolism and the compound urine screens are built to find.
• Ecgonine methyl ester forms alongside it: plasma and liver cholinesterases hydrolyze cocaine into both water-soluble metabolites, which the kidneys then excrete.
• The metabolites carry no drug effect: Mayo describes cocaine’s metabolites as inactive, which is why a positive test says nothing about current impairment.
• Concentration does not indicate dose or effect: Mayo states directly that there is no correlation between measured concentration and pharmacologic or toxic effects.
• The parent drug clears fast: cocaine’s plasma elimination half-life is reported at roughly 1 hour, far shorter than the metabolite the test targets.
• Metabolite targeting is not universal: stimulant drug classes differ here from long-acting benzodiazepines and synthetic opioids, where tests read the parent drug.

Crack and Powder Cocaine in Testing Terms

• Both forms metabolize identically: crack and powder cocaine produce the same benzoylecgonine, so a laboratory cannot distinguish them from a urine result.
• Route changes onset rather than detection chemistry: smoking freebase reaches the brain faster than intranasal use, but the metabolic pathway and detection target are unchanged.
• Freebase forms raise toxicity risk: Mayo notes that freebase and crack increase the potential for major cocaine toxicity.

What Determines How Long Cocaine Stays in Your System?

Dose, frequency of use, individual metabolism, liver and kidney function, alcohol co-use, and the laboratory’s cutoff concentration together determine how long cocaine remains detectable.

Dose and Frequency of Use

• Repeated use extends the window beyond single-dose figures: Mayo Clinic Laboratories states that actual detection time depends on dose, frequency of use, and individual metabolism.
• Binge patterns accumulate metabolite: because benzoylecgonine clears more slowly than cocaine, repeated dosing across a night raises the metabolite load the test measures.
• Effects and detection diverge sharply here: the subjective experience ends within hours while the metabolite persists for days.

How Alcohol Changes the Result

• Cocaine and alcohol together create a third drug: hepatic carboxylesterase drives a transesterification that converts cocaine into cocaethylene, described in the literature as the only known psychoactive substance formed entirely within the human body.
• Cocaethylene lasts longer than cocaine: its plasma elimination half-life is roughly 2 hours against approximately 1 hour for cocaine, which prolongs and intensifies intoxication.
• The combination is more cardiotoxic: cocaethylene is considered more toxic to the cardiovascular and hepatic systems than cocaine itself.
• Alcohol shifts the test result itself: co-ingestion decreases cocaine’s hepatic clearance, which increases the amount of unchanged cocaine excreted in urine and decreases the overall number of cocaine metabolites.
• Co-use is common rather than unusual: ethanol co-ingestion is reported in 34 percent of cocaine-related emergency department cases.

Organ Function and Individual Variation

• Cholinesterase activity sets the pace: because plasma and liver cholinesterases perform the initial hydrolysis, variation in that enzyme activity changes how quickly cocaine converts to metabolite.
• Kidney function governs clearance: the water-soluble metabolites leave through the kidneys, so impaired renal function extends the detection window.
• Serum levels are not predictable in co-use: cocaethylene concentration depends on the timing and quantities of cocaine and ethanol, and is not readily predictable from either alone.

How Long Does Cocaine Stay in Urine, Blood, Saliva, and Hair?

Cocaine metabolites remain detectable in urine for up to 4 days, in blood and saliva for a matter of hours to about a day, and in hair for approximately 90 days.

Detection Windows by Test Type

Test type	Target compound	Detection window	Source
Urine (cocaine)	Unchanged cocaine	About 1 day after last use	Mayo Clinic Laboratories
Urine (metabolite)	Benzoylecgonine	72 hours to 4 days, standard cutoffs	Mayo Clinic Laboratories
Urine (research assay)	Benzoylecgonine at a 5 ng/mL limit of quantitation	17 to 22 days	Nickley et al., 2017
Oral fluid (saliva)	Cocaine and metabolite	Approximately 24 to 48 hours	Quest Diagnostics
Blood	Cocaine and cocaethylene	Hours, shortest of the matrices	Verstraete, 2004
Hair	Incorporated drug and metabolite	Up to approximately 90 days	Quest Diagnostics

What Each Test Establishes

• Urine answers the question most people are asking: it is the default for workplace and treatment monitoring and the matrix all published cutoffs refer to.
• Blood identifies very recent use and co-use: its short window suits emergency and forensic settings, and it is where cocaethylene is most reliably identified.
• Oral fluid detects recent use with observed collection: the tradeoff is a shorter window and lower drug concentrations than urine.
• Hair describes a pattern, not an episode: a hair test provides roughly a three-month record of repeated use and is poorly suited to a single recent exposure.

Hour by Hour After the Last Dose

1. First minutes: cocaine enters the bloodstream and becomes measurable in blood and oral fluid.
2. Approximately 1 hour: one plasma half-life of cocaine has elapsed.
3. 2 to 6 hours: plasma and liver cholinesterases hydrolyze most of the dose into benzoylecgonine and ecgonine methyl ester.
4. Approximately 12 hours: one benzoylecgonine half-life has elapsed.
5. Up to 24 hours: unchanged cocaine remains present in urine.
6. 24 to 48 hours: the oral fluid window closes for most people.
7. 48 to 72 hours: benzoylecgonine remains above standard confirmatory cutoffs.
8. Up to 4 days: benzoylecgonine remains detectable in Mayo’s test documentation.
9. 17 to 22 days: the window at a research-grade 5 ng/mL cutoff rather than the standard threshold.
10. Up to 90 days: hair testing continues to reflect repeated use.

Nursing Monitoring During Cocaine Detox at New Spirit Recovery

• Cardiac observation drives the first days: Cynthia Prieto, Director of Nursing, notes that a detection window describes the laboratory picture while cardiovascular monitoring describes the clinical one, and cocaine cases make the difference obvious.
• Continuous coverage spans the withdrawal period: medically supervised detoxification runs 7 to 10 days on average and extends to 10 to 21 days on medical necessity, with 24-hour nursing and physician oversight.
• Staffing density catches early change: an approximately 1:1 staff-to-client ratio means shifts in mood, sleep, and appetite register between scheduled checks rather than at them.

Why Published Cocaine Detection Windows Disagree

Published cocaine detection windows differ because laboratories apply different cutoff concentrations, and lowering the cutoff extends the window from days to weeks.

The Cutoff Effect

• Standard thresholds were set decades ago: screening for benzoylecgonine is commonly set at 150 ng/mL with a confirmatory cutoff of 100 ng/mL.
• More than half of true positives fall below that line: Nickley, Pesce and Krock found that 51.9 percent of positive observations sat below the standard 100 ng/mL cutoff but above a 5 ng/mL threshold.
• The window stretches accordingly: at the more sensitive cutoff the detection period after cessation ran between 17 and 22 days rather than 3 to 4.
• Sensitivity is a policy choice, not a fact about the drug: this is why a treatment program, an employer, and a court can all report different windows without any of them being wrong.

Sources of Legitimate Variation

• Even one laboratory publishes more than one figure: Mayo’s test records variously describe benzoylecgonine as detectable up to 72 hours, up to 4 days, and as indicating exposure within 5 days.
• Assay technology matters: liquid chromatography-tandem mass spectrometry quantifies far lower concentrations than older immunoassay platforms.
• Individual metabolism remains the wildcard: every laboratory attaches the same caveat that dose, frequency, and metabolism govern the real number.

Cocaine Test Cutoff Levels and Confirmatory Testing

Federal workplace testing applies a 150 ng/mL initial cutoff for cocaine metabolites and a 100 ng/mL confirmatory cutoff for benzoylecgonine, and a specimen must exceed both before being reported positive.

The Two-Step Process

• Screening favors sensitivity: an initial immunoassay separates clear negatives from specimens requiring confirmation.
• Confirmation favors specificity: gas chromatography-mass spectrometry identifies cocaine and benzoylecgonine individually rather than reporting a drug class.
• Both thresholds must be cleared: a specimen below either cutoff is reported negative, so drug can be present in a negative result.
• Cutoffs were lowered from earlier standards: SAMHSA reduced the cocaine metabolite initial cutoff from 300 to 150 ng/mL and the confirmatory cutoff from 150 to 100 ng/mL.

What a Confirmation Report Names

• The report distinguishes parent drug from metabolite: Mayo’s confirmation test states specifically whether cocaine, benzoylecgonine, or both are present.
• Each finding carries a different timeframe: unchanged cocaine points to use within about a day, while benzoylecgonine alone points to earlier use.
• Interpretation belongs to a medical review officer: disputed results are resolved through confirmatory testing and clinical review rather than by rescreening.

Cocaine vs Methamphetamine Detection Windows

Cocaine clears faster than methamphetamine but leaves a longer-lasting metabolite, so the two stimulants produce different detection profiles despite similar effects.

How the Two Compare

Criterion	Cocaine	Methamphetamine
Parent drug half-life	Approximately 1 hour	Substantially longer
Compound the test targets	Benzoylecgonine, an inactive metabolite	Methamphetamine and amphetamine, both active
Urine window at standard cutoffs	Up to 4 days	Up to 3 days
Confirmatory cutoff	100 ng/mL	250 ng/mL

Why the Difference Matters Clinically

• A negative cocaine screen can still follow recent use: because the target is a metabolite with its own clearance curve, timing relative to the last dose changes the result more than dose size does.
• Methamphetamine testing reads active compounds: the contrast with methamphetamine detection windows is that both parent drug and metabolite remain psychoactive.
• Polysubstance use complicates both: combined stimulant and depressant use is assessed as polysubstance use rather than as separate isolated exposures.

Assessment When Cocaine and Alcohol Appear Together at New Spirit Recovery

• Two substances means two withdrawal profiles: Sean O’Neill, LMFT, Clinical Director, notes that clients often present cocaine as the problem and alcohol as incidental, when the cocaethylene evidence says otherwise.
• Alcohol is assessed on its own terms: alcohol use disorder treatment proceeds alongside stimulant treatment rather than after it.
• Evaluation precedes placement: clinical evaluation, medical assessment, and safety planning all occur before assignment to residential treatment.

What a Positive Cocaine Test Does and Does Not Tell You

A confirmed cocaine result establishes exposure within a defined window and nothing about dose, impairment, or diagnosis.

What a Confirmed Result Establishes

• Which compound was found: Mayo’s confirmation test states specifically whether cocaine, benzoylecgonine, or both are present.
• A rough timeframe: unchanged cocaine points to use within about a day, while benzoylecgonine alone points to earlier use.
• That both thresholds were crossed: the specimen exceeded screening and confirmatory cutoffs, which is a laboratory fact rather than a clinical conclusion.

What a Result Cannot Establish

• Dose or degree of use: Mayo states there is no correlation between measured concentration and pharmacologic or toxic effects.
• Current impairment: cocaine’s effects end within hours while the metabolite persists for days.
• Whether a use disorder exists: a single result cannot diagnose stimulant use disorder, which requires assessment against DSM-5-TR criteria.
• Whether physical damage has occurred: testing does not detect septal and nasal tissue destruction, which requires separate clinical examination.

When Cocaine Use Becomes a Medical Emergency

• Seek emergency care for chest pain: chest pain, pressure, or pain radiating to the arm or jaw after cocaine use can signal myocardial infarction.
• Seek emergency care for irregular heartbeat or breathing difficulty: arrhythmias are a recognized consequence of cocaine and cocaethylene exposure.
• Seek emergency care for sudden neurological symptoms: weakness, facial droop, or speech difficulty can indicate stroke, documented in cocaine and alcohol co-use.
• Seek emergency care for seizures or very high temperature: both feature in acute stimulant toxicity and are managed with benzodiazepines and cooling.
• Risk rises when alcohol is involved: cocaethylene potentiates the cardiotoxic effects of cocaine and alcohol taken alone.

When a Result Warrants Clinical Assessment

• The Drug Abuse Screening Test (DAST-10) offers a brief entry point: this 10-item questionnaire scores drug-related problems from 0 to 10, with higher scores indicating greater severity.
• DSM-5-TR criteria establish the diagnosis: stimulant use disorder is assessed against 11 criteria, with severity graded by the number met rather than by quantity used.
• Persistent low mood after stopping is a clinical signal: anhedonia and depressed mood can outlast the acute crash and warrant assessment rather than waiting.

Treatment After a Confirmed Cocaine Result

Behavioral therapy leads cocaine treatment because no medication holds FDA approval for stimulant use disorder.

Why Behavioral Treatment Leads

• Contingency management carries the strongest evidence: reinforcing documented abstinence has produced the most reliable outcomes for stimulant use disorder specifically.
• The Matrix Model was designed for stimulant users: developed by Richard A. Rawson and colleagues at UCLA, this structured protocol combines relapse prevention, family education, and social support.
• No approved medication treats the disorder: the 2024 ASAM and AAAP clinical practice guideline on stimulant use disorder therefore centers behavioral treatment.
• Cardiac assessment belongs in the workup: given cocaine’s cardiovascular profile, medical evaluation at intake is not a formality.

Emerging and Investigational Options

• Several agents remain under study without approval: multiple pharmacological candidates have been trialled for cocaine use disorder and none has achieved FDA approval for the indication.
• Repetitive transcranial magnetic stimulation is being investigated: rTMS is under study for stimulant craving reduction and is not approved for this use.
• State policy is expanding contingency management access: California became the first state approved to cover contingency management through Medicaid, delivered as the Recovery Incentives Program for Medi-Cal beneficiaries.

Where Assessment Happens

• A positive test is a referral point, not a treatment plan: clinical evaluation and medical assessment establish level of care.
• Signs and consequences are assessed separately: the broader picture of cocaine dependence covers symptoms a test cannot show.
• Alcohol co-use is assessed on its own terms: concurrent drinking is evaluated as its own condition rather than as a secondary detail.

Treatment at New Spirit Recovery

New Spirit Recovery provides medical detoxification and residential treatment for cocaine addiction across three licensed locations in the Los Angeles area.

Medical Detoxification

• Duration follows medical necessity: detoxification averages 7 to 10 days and extends to 10 to 21 days when the medical team determines it is warranted.
• Supervision does not pause: 24-hour medical and nursing coverage operates with physician oversight, and registered alcohol and drug technicians staff all shifts.
• Medication review is scheduled: physician consultations occur at minimum weekly under Medical Director and Nurse Practitioner oversight.

Residential Treatment

• Programming fills the week: David Ressler, Program Director, structures 6 hours of daily programming across 7 days within a 35-day course, on the view that unstructured time is where early stimulant recovery fails.
• Groups address the binge cycle directly: daily programming includes relapse prevention, trigger identification, distress tolerance training, step work, CBT and DBT groups, expressive arts therapy, and Rock to Recovery.
• Individual therapy is a floor, not a cap: clients receive weekly individual sessions at minimum, increased according to acuity.
• Settings stay small: the Tarzana, Northridge, and Encino locations run at 3 to 12 beds each.

The Rewired Curriculum

• Rewired is specific to New Spirit Recovery: the Rewired curriculum runs across ten modules covering emotional regulation, stress management, self-awareness, trigger identification, healthy boundaries, and personal accountability.
• Trigger work suits a short-cycle drug: because cocaine use tends to cluster around specific settings and social contexts, the trigger identification module maps those situations rather than counting abstinence days.
• Skills work runs parallel to clinical care: Rewired groups sit alongside the evidence-based modalities rather than replacing them.

Step-Down and Continuing Care

• Care reduces in stages: step-down programming moves through partial hospitalization with sober living coordination, intensive outpatient, and outpatient levels.
• Community integration is scheduled: weekend programming emphasizes reintegration in line with the fourth dimension of the ASAM criteria, including outside Alcoholics Anonymous, Narcotics Anonymous, and Dharma Recovery meetings.
• Family work continues throughout: family therapy, education, and ongoing sessions run across the stay rather than in a single scheduled block.

Frequently Asked Questions

How long do I test positive for cocaine?

At standard laboratory cutoffs, a urine test typically reads positive for up to 4 days after last use, because it detects benzoylecgonine rather than cocaine. Unchanged cocaine itself is present for roughly 1 day. Heavier or more frequent use extends both figures.

How long can you test cocaine for?

The ceiling depends entirely on the matrix and the cutoff. Hair testing reflects roughly 90 days of repeated use, urine covers days, and blood covers hours. Research assays set at 5 ng/mL rather than the standard 100 ng/mL have detected benzoylecgonine for 17 to 22 days.

What is the 100 to 1 rule for cocaine?

This refers to United States sentencing law, not pharmacology. Federal law historically treated crack cocaine and powder cocaine at a 100 to 1 quantity ratio for sentencing purposes, a disparity later reduced by the Fair Sentencing Act of 2010. Both forms are chemically identical in metabolism and testing.

What is a cocaine washout?

A washout period is the interval a clinician allows for cocaine and its metabolites to clear before a procedure or an assessment, most often discussed before surgery or anesthesia. The length depends on the clinical question being asked. Any washout decision belongs to the treating physician.

How long does crack stay in your system?

Crack cocaine produces the same benzoylecgonine as powder cocaine, so detection windows are effectively identical at up to 4 days in urine. Smoking delivers the drug faster, which changes onset and intensity rather than clearance. A laboratory cannot distinguish crack from powder on a urine result.

Does cocaine show up on a 5-panel drug test?

Yes. Cocaine metabolites are one of the five drug classes in the standard federal 5-panel screen, alongside amphetamines, marijuana, opiates, and phencyclidine. The panel targets benzoylecgonine at a 150 ng/mL screening cutoff.

How long does a cocaine crash last?

Acute crash symptoms including fatigue, heavy sleep, increased appetite, and low mood generally occupy the first several days after a binge ends. Anhedonia and depressed mood can persist considerably longer. Persistent low mood after stopping warrants clinical assessment rather than waiting it out.

Can secondhand exposure cause a positive cocaine test?

Passive environmental exposure is very unlikely to exceed confirmatory cutoffs, which are set specifically to exclude incidental contact. Handling contaminated currency or surfaces does not typically produce a positive confirmed result. Disputed results should be reviewed with a medical review officer.

References

1. Mayo Clinic Laboratories. (2026). Cocaine and metabolite confirmation, random, urine (COKEU). Test catalog. APA citation only.
2. Nickley, J., Pesce, A. J., & Krock, K. (2017). A sensitive assay for urinary cocaine metabolite benzoylecgonine shows more positive results and longer half-lives than those using traditional cut-offs. Drug Testing and Analysis, 9(7), 1043-1047. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573903/
3. Pergolizzi, J., Breve, F., Magnusson, P., LeQuang, J. A., & Varrassi, G. (2022). Cocaethylene: When cocaine and alcohol are taken together. Cureus, 14(2), e22498. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956485/
4. Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007, NSDUH Series H-60). Center for Behavioral Health Statistics and Quality. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases
5. Clinical Guideline Committee Members, ASAM Team, AAAP Team, & IRETA Team. (2024). The ASAM/AAAP clinical practice guideline on the management of stimulant use disorder. Journal of Addiction Medicine, 18(1S Suppl 1), 1-56.
6. Verstraete, A. G. (2004). Detection times of drugs of abuse in blood, urine, and oral fluid. Therapeutic Drug Monitoring, 26(2), 200-205.
7. Hearn, W. L., Flynn, D. D., Hime, G. W., Rose, S., Cofino, J. C., Mantero-Atienza, E., Wetli, C. V., & Mash, D. C. (1991). Cocaethylene: A unique cocaine metabolite displays high affinity for the dopamine transporter. Journal of Neurochemistry, 56(2), 698-701.
8. Quest Diagnostics. (2023). Hair drug testing: Frequently asked questions. Employer Solutions. APA citation only.
9. Substance Abuse and Mental Health Services Administration. (2024). Regulatory program updates: Mandatory guidelines for federal workplace drug testing programs. Drug Testing Advisory Board. APA citation only.
10. California Department of Health Care Services. (2025). Recovery Incentives Program: California’s contingency management benefit. APA citation only.